SCIENCE-FUTUR
123 views | +0 today
Follow
SCIENCE-FUTUR
innovation, surprise, prospective
Curated by Muriel Gosnat
Your new post is loading...
Your new post is loading...
Scooped by Muriel Gosnat
Scoop.it!

CANCER COLORECTAL: Premier pas vers le test immunologique

CANCER COLORECTAL: Premier pas vers le test immunologique | SCIENCE-FUTUR | Scoop.it
Le lancement, le 27 janvier, de l’appel d’offres européen pour des tests immunologiques, nécessaires au dépistage organisé du cancer colorectal, devrait permettre leur mise à disposition en France avant la fin de l’année, informe le Ministère de la...
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Une protéine permettrait de prédire les risques de diabète de type 2 | Médecine

Une protéine permettrait de prédire les risques de diabète de type 2 | Médecine | SCIENCE-FUTUR | Scoop.it
Des chercheurs montréalais ont découvert qu'une protéine située dans les tissus musculaires pourrait contribuer au développement du diabète de type 2 à l'âge adulte.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Dooderm invente le tissu qui apaise les démangeaisons

Dooderm invente le tissu qui apaise les démangeaisons | SCIENCE-FUTUR | Scoop.it
Après quatre ans de recherches, Françoise Raverdy (photo) a créé une gamme de seize vêtements inédits en France, baptisés Dooderm, qui...
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Nanotech Vaccine Promising Against Infections | MIT Technology Review

Nanotech Vaccine Promising Against Infections | MIT Technology Review | SCIENCE-FUTUR | Scoop.it
A novel vaccine design could lead to new weapons against often deadly bacterial infections.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

UEA scientists make advance in cancer research - Pharmaceutical Business Review

A protein that has been at the centre of cancer drug design for the last 20 years should not be given up on according to new research from the Univers
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Baxter submits BLA to FDA for OBI-1 approval to treat acquired hemophilia A - Pharmaceutical Business Review

Baxter International has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for the approval of a recombinan
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Portola reports additional positive results from Phase II trial of new Factor Xa inhibitor antidote - Pharmaceutical Business Review

Portola Pharmaceuticals has reported additional results of a Phase II proof-of-concept study that demonstrated andexanet alfa's (PRT4445) ability to i
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

GlaxoSmithKline, Theravance release positive Phase III asthma trial results - Pharmaceutical Business Review

GlaxoSmithKline (GSK) and Theravance have reported positive results from a 12 week, double-blind, parallel group, multi-center Phase III trial of flut
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Baxter submits application to FDA for pediatric indication of Rixubis to treat Hemophilia B - Pharmaceutical Business Review

Baxter International has filed an application to the US Food and Drug Administration (FDA) for a pediatric indication for Rixubis [Coagulation Factor
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Novo's IDegLira shows better blood sugar control in Phase III trial - Pharmaceutical Business Review

Novo Nordisk has said that a Phase III trial of its diabetes drug IDegLira showed better control of blood sugar levels (HbA1c) compared to long-acting
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

TG Therapeutics launches combination clinical trial of TG-1101 and Ibrutinib - Pharmaceutical Business Review

TG Therapeutics, a biopharmaceutical company, has initiated a multi-center Phase II clinical trial to evaluate the safety and efficacy of the combinat
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Medical Glasses Let Nurses See Patients' Veins Through Their Skin - PSFK

Medical Glasses Let Nurses See Patients' Veins Through Their Skin - PSFK | SCIENCE-FUTUR | Scoop.it
Eyes-On Glasses help give doctors and medical staff the power of x-ray vision.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Diabète : des lentilles de contact pour mesurer le taux de sucre ! - High tech - Patientsworld

Diabète : des lentilles de contact pour mesurer le taux de sucre ! - High tech - Patientsworld | SCIENCE-FUTUR | Scoop.it
Sera-t-il possible un jour de suivre son taux de sucre grâce au port de lentilles de contact ?
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Cellectis exploite les vertus thérapeutiques des feuilles de tabac

Cellectis exploite les vertus thérapeutiques des feuilles de tabac | SCIENCE-FUTUR | Scoop.it
Si le tabac est nuisible pour la santé, les vertus de cette plante sont mal exploitées. C'est précisément pour améliorer les protéines...
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

AstraZeneca to buy stake in Bristol-Myers Squibb's diabetes business for $4.1bn - Pharmaceutical Business Review

AstraZeneca to buy stake in Bristol-Myers Squibb's diabetes business for $4.1bn - Pharmaceutical Business Review | SCIENCE-FUTUR | Scoop.it
AstraZeneca has agreed to acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for $4.1bn including an initial
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

A Missing Genetic Link in Human Evolution | Simons Foundation

A Missing Genetic Link in Human Evolution | Simons Foundation | SCIENCE-FUTUR | Scoop.it
Mysterious episodes of genetic duplication in our great ape ancestors may have paved the way for human evolution.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Sunovion releases pooled Phase III trial results of Aptiom - Pharmaceutical Business Review

Sunovion Pharmaceuticals has reported results from a pooled analysis of three Phase III randomised, placebo-controlled trials including 301, 302 and 3
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Gilead Sciences receives FDA approval for chronic hepatitis C drug - Pharmaceutical Business Review

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleo
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Gilead reports interim Phase II trial results of tumor drug - Pharmaceutical Business Review

Gilead reports interim Phase II trial results of tumor drug - Pharmaceutical Business Review | SCIENCE-FUTUR | Scoop.it
Gilead Sciences has reported interim results from a single-arm, open-label Phase II trial assessing an investigational oral inhibitor of spleen tyrosi
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Idenix Pharma begins Phase II combination trial to treat hepatitis C virus infection - Pharmaceutical Business Review

US-based biopharmaceutical company Idenix Pharmaceuticals has started patient enrollment in the Phase II HELIX-2 clinical trial evaluating an all-oral
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

OncoMed starts third Phase Ib combination therapy trial of pancreatic cancer - Pharmaceutical Business Review

US-based OncoMed Pharmaceuticals has started a Phase Ib clinical trial of its Wnt-pathway-targeting antibody vantictumab (OMP-18R5) in combination wit
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Researchers may have discovered a plan to disable Meniere's disease

Researchers may have discovered a plan to disable Meniere's disease | SCIENCE-FUTUR | Scoop.it
Researchers may have figured out what causes Meniere's disease and how to attack it: there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches, their work...
more...
No comment yet.